TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 18.75
+1.55 (9.01%)
Oct 20, 2026, 1:58 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 3.54 billion as of October 20, 2026. It is the 21,061st most valuable company in the world and the 978th biggest in Taiwan. Its market cap has decreased by 1.34% in one year.
Market Cap
3.54B
Enterprise Value
3.43B
Revenue
n/a
Global Rank
Country Rank
#978 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has decreased from 3.83B to 3.54B, a decrease of -7.63%. That is a compound annual growth rate of -0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 3.54B | 95.55% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 11.90B |
| TCM Biotech International | 9.67B |
| Locus Cell | 8.71B |
| PharmaEngine | 8.25B |
| Tanvex BioPharma | 8.11B |
| Adimmune | 7.76B |
| Acepodia | 7.70B |
| OBI Pharma | 7.49B |